Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.46 USD | -2.54% | -1.98% | +26.74% |
06-13 | Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial | CI |
05-20 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.74% | 29.49M | |
+17.72% | 44.44B | |
-10.33% | 37.99B | |
+37.55% | 37.75B | |
+29.36% | 30.78B | |
-8.44% | 27.38B | |
+12.45% | 26.17B | |
+44.19% | 14.15B | |
+31.93% | 12.59B | |
-7.67% | 11.28B |
- Stock Market
- Equities
- LSTA Stock
- News Lisata Therapeutics, Inc.
- Caladrius Biosciences : Brookline Capital Management Adjusts Caladrius Biosciences PT to $10 From $7, Maintains Buy Rating